ALDX

1.83

2.23% 0.04

Vorhandelsmarkt: 1.83

Aldeyra Therapeutics Inc (ALDX)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$1.79

Offen:

$1.8

24-Stunden-Volumen:

1.80M

Relative Volume:

0.64

Marktkapitalisierung:

$110.13M

Einnahmen:

Nettoeinkommen (Verlust:

$-33.85M

KGV:

-3.2458

EPS:

-0.5638

Netto-Cashflow:

$-33.35M

1W Leistung:

+16.56%

1M Leistung:

-55.64%

6M Leistung:

-67.67%

1J Leistung:

-16.82%

1-Tages-Spanne:

$1.77

$1.87

1-Wochen-Bereich:

$1.52

$1.89

52-Wochen-Spanne:

$1.07

$6.175

Aldeyra Therapeutics Inc Stock (ALDX) Company Profile

Firmenname

Aldeyra Therapeutics Inc

Sektor

Healthcare (1112)

Branche

Biotechnology (621)

Telefon

781-761-4904

Adresse

131 HARTWELL AVENUE, LEXINGTON, MA

Mitarbeiter

Twitter

@aldeyraaldx

Nächster Verdiensttermin

2025-08-08

Neueste SEC-Einreichungen

ALDX's Discussions on Twitter

Compare ALDX vs VRTX, REGN, ARGX, ALNY, ONC

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
ALDX Aldeyra Therapeutics Inc	1.83	107.73M	0	-33.85M	-33.35M	-0.5638
VRTX Vertex Pharmaceuticals Inc	441.70	113.01B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	753.93	79.87B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	840.87	51.51B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	333.39	45.29B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	319.94	34.41B	5.36B	287.73M	924.18M	2.5229

Aldeyra Therapeutics Inc Stock (ALDX) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-03-18	Herabstufung	H.C. Wainwright	Buy → Neutral
2024-04-03	Hochstufung	Oppenheimer	Perform → Outperform
2024-04-02	Fortgesetzt	H.C. Wainwright	Buy
2022-04-27	Fortgesetzt	H.C. Wainwright	Buy
2021-02-08	Eingeleitet	H.C. Wainwright	Buy
2020-12-16	Eingeleitet	Berenberg	Buy
2020-10-30	Eingeleitet	Jefferies	Buy
2020-10-16	Eingeleitet	BTIG Research	Buy
2020-09-22	Eingeleitet	Alliance Global Partners	Buy
2020-05-12	Eingeleitet	Oppenheimer	Outperform
2018-12-04	Eingeleitet	Citigroup	Buy
2018-09-26	Bestätigt	Cantor Fitzgerald	Overweight
2018-09-13	Eingeleitet	Janney	Buy
2018-01-26	Eingeleitet	Seaport Global Securities	Buy
2016-09-26	Eingeleitet	H.C. Wainwright	Buy
2016-07-01	Eingeleitet	Stifel	Buy
2015-07-01	Eingeleitet	Canaccord Genuity	Buy
2015-03-25	Eingeleitet	Chardan Capital Markets	Buy
2015-03-20	Bestätigt	H.C. Wainwright	Buy
2014-11-18	Eingeleitet	H.C. Wainwright	Buy
2014-06-19	Eingeleitet	Aegis Capital	Buy

Alle ansehen

Aldeyra Therapeutics Inc Aktie (ALDX) Neueste Nachrichten

01:41 AM

Robbins LLP Investigating Aldeyra Therapeutics for Misleading Investors - National Today

01:41 AM

Apr 15, 2026

Robbins LLP Encourages ADLX Stockholders Who Lost Money Investing in Aldeyra Therapeutics, Inc. to Contact the Firm for Information About Leading the Class Action - PR Newswire

Apr 15, 2026

Bragar Eagel & Squire, P.C. Encourages Aldeyra Therapeutics, Inc. Investors to Contact the ... - Bluefield Daily Telegraph

Apr 15, 2026

Bragar Eagel & Squire, P.C. Encourages Aldeyra - GlobeNewswire

Apr 15, 2026

Bragar Eagel & Squire, P.C. Encourages Aldeyra Therapeutics, Inc. Investors to Contact the Firm Regarding Their Rights - GlobeNewswire Inc.

Apr 15, 2026

ALDX Investors Have Opportunity to Lead Aldeyra Therapeutics, In - GuruFocus

Apr 15, 2026

ALDX Investors Have Opportunity to Lead Aldeyra Therapeutics, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm - Barchart.com

Apr 15, 2026

Bronstein, Gewirtz & Grossman LLC Urges Aldeyra - GlobeNewswire

Apr 15, 2026

ALDX Investor Alert: Aldeyra Therapeutics Securities Fraud LawsuitInvestors With Losses May Seek to Lead the Class Action After Executives Allegedly Reiterated Misleading Claims: Levi & Korsinsky - PR Newswire

Apr 15, 2026

Apr 14, 2026

Aldeyra Therapeutics (ALDX) price target decreased by 22.41% to 7.65 - MSN

Apr 14, 2026

ALDX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aldeyra Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Apr 14, 2026

ALDX Investors Have Opportunity to Lead Aldeyra Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire

Apr 14, 2026

Apr 13, 2026

ALDX Investor Alert: Aldeyra Therapeutics Securities Fraud - GlobeNewswire

Apr 13, 2026

Market Recap: Can Aldeyra Therapeutics Inc maintain sales growthDividend Hike & Verified Momentum Watchlists - baoquankhu1.vn

Apr 13, 2026

ALDX SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Aldeyra Therapeutics (ALDX) Investors of Securities Class Action Deadline on May 29, 2026 - Sahm

Apr 13, 2026

ALDX Stock Price, Quote & Chart | ALDEYRA THERAPEUTICS INC (NASDAQ:ALDX) - ChartMill

Apr 13, 2026

Apr 12, 2026

Bronstein, Gewirtz & Grossman LLC Urges Aldeyra Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - mydailyrecord.com

Apr 12, 2026

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Aldeyra Therapeutics, Inc. Investors with Losses in ... - Bluefield Daily Telegraph

Apr 12, 2026

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Aldeyra Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - GlobeNewswire Inc.

Apr 12, 2026

ROSEN, THE FIRST FILING FIRM, Encourages Trip.com Group Limited Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - GlobeNewswire Inc.

Apr 12, 2026

ALDX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aldeyra Therapeutics, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Apr 12, 2026

Rosen Law Firm Encourages Aldeyra Therapeutics Investors to Secure Counsel Before Upcoming Deadline - National Today

Apr 12, 2026

Apr 11, 2026

Did You Lose Money Investing in Aldeyra Therapeutics, Inc.? Robbins LLP Urges Investors with Significant Losses to Contact the Firm for Information About Their Rights Against ADLX - ACCESS Newswire

Apr 11, 2026

Apr 10, 2026

Portnoy Law Firm Announces Class Action on Behalf of Aldeyra Therapeutics, Inc. Investors - GlobeNewswire

Apr 10, 2026

2026-04-10 | Did You Lose Money Investing in Aldeyra Therapeutics, Inc.? Robbins LLP Urges Investors with Significant Losses to Contact the Firm for Information About Their Rights Against ADLX | NDAQ:ALDX | Press Release - Stockhouse

Apr 10, 2026

ALDX Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Aldeyra ... - Bluefield Daily Telegraph

Apr 10, 2026

ALDX Shareholder Alert: Investors With Losses May Seek to - GlobeNewswire

Apr 10, 2026

ALDX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aldeyra Therapeutics, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Apr 10, 2026

Press releases provided by CNW - Techaeris

Apr 10, 2026

Apr 09, 2026

ROSEN, A LEADING AND RANKED FIRM, Encourages Aldeyra Therapeutics, Inc. Investors to Secure ... - Bluefield Daily Telegraph

Apr 09, 2026

ROSEN, A LEADING AND RANKED FIRM, Encourages Aldeyra - GlobeNewswire

Apr 09, 2026

ROSEN, A LEADING AND RANKED FIRM, Encourages Aldeyra Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - GlobeNewswire Inc.

Apr 09, 2026

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Aldeyra Therapeutics, Inc. Of Class Action Lawsuit and Upcoming DeadlinesALDX - PR Newswire

Apr 09, 2026

ALDX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aldeyra Therapeutics, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Apr 09, 2026

BTIG Maintains Buy on Aldeyra Therapeutics (ALDX) March 2026 - Meyka

Apr 09, 2026

Published on: 2026-04-09 11:55:34 - baoquankhu1.vn

Apr 09, 2026

Apr 08, 2026

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Bronstein, Gewirtz & Grossman, LLC (ALDX) And Encourages Investors to Reach Out - ACCESS Newswire

Apr 08, 2026

ALDX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aldeyra Therapeutics, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Apr 08, 2026

Aldeyra Therapeutics (NASDAQ:ALDX) Share Price Crosses Below 50-Day Moving AverageWhat's Next? - MarketBeat

Apr 08, 2026

Is Aldeyra Therapeutics Inc stock trending bullishEarnings Risk Summary & Weekly Breakout Watchlists - baoquankhu1.vn

Apr 08, 2026

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Aldeyra ... - Black Hills Pioneer

Apr 08, 2026

Shareholders who lost money in Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) Should Contact Wolf Haldenstein Immediately - Finviz

Apr 08, 2026

ALDX Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Aldeyra Therapeutics, Inc. Securities Lawsuit -- The Gross Law Firm - Sahm

Apr 08, 2026

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Aldeyra Therapeutics, Inc. (ALDX) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire

Apr 08, 2026

Apr 07, 2026

ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Aldeyra Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the FirmALDX - ACCESS Newswire

Apr 07, 2026

ALDX STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aldeyra Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Apr 07, 2026

ALDX Shareholder Alert: Investors With Losses May Seek to Lead t - GuruFocus

Apr 07, 2026

ALDX Investors Have Opportunity to Lead Aldeyra Therapeutics Securities Fraud Lawsuit - National Today

Apr 07, 2026